KAISA JiaYun Technology Inc

On the evening of July 29, multiple listed companies on the Shanghai and Shenzhen stock exchanges released important announcements. Tianzhihang plans to acquire a 62% stake in Shanghai Minimally Invasive Orthopaedics Medical Technology Co., Ltd. through a share issuance and raise supporting funds, with trading in its shares resuming on July 30. GigaDevice Chairman Zhu Yiming proposed a share buyback of 1 to 2 billion yuan for cancellation, and also plans to increase his holdings in the company by no less than 1 billion yuan. Entive Smart Kitchen's wholly-owned subsidiary Gansu Yisuan signed a computing power resource service contract worth 1.106 billion yuan, while Yongding Co.'s controlling subsidiary Suzhou Dingxin Optoelectronics signed an order for high-power laser chips worth approximately 1.133 billion yuan. Western Mining disclosed its half-year report, with net profit for the first half reaching 4.169 billion yuan, up 123% year-on-year. In addition, companies such as Lianchuang Electronics and Jiayun Technology are set to see changes in their actual controllers, and Hua Wen will have its delisting risk warning removed starting July 31.

Tinavi Medical announced plans to acquire a 62% stake in Shanghai Orthopaedics, expected to constitute a major asset restructuring, with trading in its shares to resume tomorrow. Yongding Co.'s controlling subsidiary has received purchase orders for high-power laser chip products worth approximately 1.133 billion yuan over the past month. Xingyun Technology's wholly-owned subsidiary has signed a supplementary agreement for computing power services, increasing the contract value to 3.053 billion yuan, up 201.14% from the original agreement. Jiayun Technology shareholder Ruineng Co. plans to acquire an 18.31% stake through a negotiated transfer, and trading in the shares will resume. Lianchuang Electronics' controlling shareholder is set to change to Shouxian Xinqiao, and trading in the shares will resume. GigaDevice Chairman Zhu Yiming has proposed a buyback of A-shares worth between 1 billion and 2 billion yuan for cancellation, and plans to increase his holdings by no less than 1 billion yuan. Sinosun Technology is planning a change of control, and trading in its shares has been suspended. Zijin Mining's controlling subsidiary has terminated its acquisition of Union Gold and plans to subscribe for a 9.2% stake in the company. Huawen Media has had its delisting risk warning removed but will continue to be subject to other risk warnings, with its stock abbreviation changed to ST Huawen. Hailiang Co.'s controlling shareholder has received a commitment letter for an 860 million yuan shareholding increase loan. Huajin Co. Vice General Manager Yan Zenghui has been placed under investigation and subjected to detention measures. Hengrui Medicine's insulin degludec injection has been approved for marketing for the treatment of type 2 diabetes in adults, making it the first domestically developed long-acting insulin analogue in China.